These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 39114648

  • 21. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.
    Javed S, Mirani ZA, Pirzada ZA.
    Libyan J Med; 2021 Dec; 16(1):1845444. PubMed ID: 33170767
    [Abstract] [Full Text] [Related]

  • 22. Glycosuria Alters Uropathogenic Escherichia coli Global Gene Expression and Virulence.
    Islam MJ, Bagale K, John PP, Kurtz Z, Kulkarni R.
    mSphere; 2022 Jun 29; 7(3):e0000422. PubMed ID: 35477301
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.
    Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ.
    Nat Chem Biol; 2009 Dec 29; 5(12):913-9. PubMed ID: 19915538
    [Abstract] [Full Text] [Related]

  • 27. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
    Zhao F, Yang H, Bi D, Khaledi A, Qiao M.
    Microb Pathog; 2020 Jul 29; 144():104196. PubMed ID: 32283258
    [Abstract] [Full Text] [Related]

  • 28. Nitrate Metabolism Modulates Biosynthesis of Biofilm Components in Uropathogenic Escherichia coli and Acts as a Fitness Factor During Experimental Urinary Tract Infection.
    Martín-Rodríguez AJ, Rhen M, Melican K, Richter-Dahlfors A.
    Front Microbiol; 2020 Jul 29; 11():26. PubMed ID: 32082279
    [Abstract] [Full Text] [Related]

  • 29. Community behavior and amyloid-associated phenotypes among a panel of uropathogenic E. coli.
    Lim JY, Pinkner JS, Cegelski L.
    Biochem Biophys Res Commun; 2014 Jan 10; 443(2):345-50. PubMed ID: 24239885
    [Abstract] [Full Text] [Related]

  • 30. Genetic diversity and virulence characteristics of biofilm-producing uropathogenic Escherichia coli.
    Qasemi A, Rahimi F, Katouli M.
    Int Microbiol; 2022 May 10; 25(2):297-307. PubMed ID: 34705131
    [Abstract] [Full Text] [Related]

  • 31. Effect of sub-minimal inhibitory concentration ceftazidime on the pathogenicity of uropathogenic Escherichia coli.
    Feng W, Zhang L, Yuan Q, Wang Y, Yao P, Xia P, Sun F.
    Microb Pathog; 2021 Feb 10; 151():104748. PubMed ID: 33484810
    [Abstract] [Full Text] [Related]

  • 32. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S, Shahrokhi N, Khalaj V, Habibi M, Moazzezy N, Asadi Karam MR, Bouzari S.
    Microb Pathog; 2020 Apr 10; 141():103974. PubMed ID: 31926238
    [Abstract] [Full Text] [Related]

  • 33. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ.
    mBio; 2016 Apr 12; 7(2):e00104-16. PubMed ID: 27073089
    [Abstract] [Full Text] [Related]

  • 34. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
    Shea AE, Frick-Cheng AE, Smith SN, Mobley HLT.
    mSystems; 2022 Dec 20; 7(6):e0082722. PubMed ID: 36445110
    [Abstract] [Full Text] [Related]

  • 35. Variation in the ratio of curli and phosphoethanolamine cellulose associated with biofilm architecture and properties.
    Jeffries J, Thongsomboon W, Visser JA, Enriquez K, Yager D, Cegelski L.
    Biopolymers; 2021 Jan 20; 112(1):e23395. PubMed ID: 32894594
    [Abstract] [Full Text] [Related]

  • 36. An optotracer-based antibiotic susceptibility test specifically targeting the biofilm lifestyle of Salmonella.
    Eckert JA, Rosenberg M, Rhen M, Choong FX, Richter-Dahlfors A.
    Biofilm; 2022 Dec 20; 4():100083. PubMed ID: 36117547
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
    Sheikhi R, Amini ME, Alidoust L, Atrkar Roushan Z, Nikokar I.
    J Infect Dev Ctries; 2024 May 30; 18(5):761-769. PubMed ID: 38865401
    [Abstract] [Full Text] [Related]

  • 38. Phylogenetic analysis, biofilm formation, antimicrobial resistance and relationship between these characteristics in Uropathogenic Escherichia coli.
    Talieh Mostaghimi, Pournajaf A, Bijani A, Mohammadi M, Rajabnia M, Halaji M.
    Mol Biol Rep; 2024 Feb 23; 51(1):327. PubMed ID: 38393446
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Carvacrol-rich oregano oil and thymol-rich thyme red oil inhibit biofilm formation and the virulence of uropathogenic Escherichia coli.
    Lee JH, Kim YG, Lee J.
    J Appl Microbiol; 2017 Dec 23; 123(6):1420-1428. PubMed ID: 28980415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.